MedTrace Logo

Accexible Speech Analysis for MCI Detection and Monitoring in Colombia

NCT07553117 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114

Last updated 2026-05-08

No results posted yet for this study

Summary

Mild Cognitive Impairment (MCI) is frequently underdiagnosed due to its subtle clinical presentation. This study evaluates the diagnostic performance of AcceXible, a speech analysis-based machine learning platform, compared to the Montreal Cognitive Assessment (MoCA) for MCI detection and monitoring in Colombian patients.

A diagnostic test accuracy study will be conducted within a primary care setting (EPS Sanitas), including prior validation of the AcceXible protocol in the Colombian healthcare context.

The study pursues two primary aims: (1) to validate the AcceXible tool in a Colombian population, and (2) to demonstrate that AcceXible achieves high diagnostic accuracy for early MCI detection and longitudinal monitoring relative to the MoCA.

Conditions

Interventions

DEVICE

Accexible

Speech Analysis Tool

Sponsors & Collaborators

  • Fundación Universitaria Sanitas (UNISANITAS)

    collaborator UNKNOWN

  • Accexible

    lead INDUSTRY

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-22
Primary Completion
2024-06-17
Completion
2024-06-17

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07553117 on ClinicalTrials.gov